Ribonucleic Acid (RNA) Editing Global Market Report 2025

Description

Ribonucleic acid (RNA) editing is a post-transcriptional mechanism that modifies the nucleotide sequence of RNA molecules after they are transcribed from deoxyribonucleic acid (DNA). These modifications can alter the structure or function of the resulting protein, thereby influencing gene expression and presenting potential therapeutic opportunities.

The primary types of RNA editing include messenger RNA (mRNA) modification, transfer RNA (tRNA) modification, and ribosomal RNA (rRNA) modification. Messenger RNA modification involves chemical alterations to mRNA molecules after transcription, such as methylation or nucleotide sequence changes. Common techniques include nucleotide insertion or deletion and deamination. These modifications have applications in treating conditions such as cancer, genetic disorders, and transient ailments.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

The ribonucleic acid (RNA) editing market research report is one of a series of new reports from The Business Research Company that provides ribonucleic acid (RNA) editing market statistics, including the ribonucleic acid (RNA) editing industry's global market size, regional shares, competitors with the ribonucleic acid (RNA) editing market share, detailed ribonucleic acid (RNA) editing market segments, market trends and opportunities, and any further data you may need to thrive in the ribonucleic acid (RNA) editing market. This ribonucleic acid (RNA) editing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The ribonucleic acid (RNA) editing market size has grown strongly in recent years. It will grow from $16.10 billion in 2024 to $17.55 billion in 2025 at a compound annual growth rate (CAGR) of 9.0%. The growth in the historic period can be attributed to the rising demand for transient and reversible RNA editing methods, expanding applications in neurodegenerative disease research, increasing prevalence of rare and orphan diseases, growing interest in synthetic biology and bioengineering, and heightened academic and translational research activities.

The ribonucleic acid (RNA) editing market size is expected to see strong growth in the next few years. It will grow to $24.42 billion in 2029 at a compound annual growth rate (CAGR) of 8.6%. The growth in the forecast period can be attributed to the rising prevalence of genetic disorders, expanding emphasis on personalized medicine, increasing applications in cancer therapy, advancements in delivery systems, and growing support from government and regulatory agencies. Major trends during this period include innovations in RNA editing platforms, progress in in vivo delivery technologies, advancements in sequencing and transcriptomics, development of transient gene modulation techniques, and expansion of synthetic biology applications.

The rising prevalence of genetic disorders is driving growth in the ribonucleic acid (RNA) editing market. Genetic disorders, caused by inherited or spontaneous mutations, are becoming more common partly due to increasing parental age, which raises the likelihood of chromosomal abnormalities. RNA editing enables treatment by correcting mutations at the RNA level, allowing cells to produce functional proteins without changing the underlying DNA. For example, as of May 2024, sickle cell disease affects approximately 100,000 people in the United States, illustrating the significant need for RNA-based therapeutic approaches.

Companies in the RNA editing market are advancing innovative approaches such as in vivo gene editing, which directly alters genes within living cells to correct disease-causing mutations. In April 2024, the Rett Syndrome Research Trust launched the MECP2 Editing Consortium to develop RNA and DNA editing therapies targeting the genetic causes of Rett syndrome. By combining expertise from six leading laboratories, the consortium aims to accelerate clinical development of precise, potentially curative treatments for this neurological disorder.

In May 2025, Rznomics Inc., a South Korea-based biopharmaceutical company, partnered with Eli Lilly and Company to develop RNA-editing therapies for sensorineural hearing loss. Rznomics is utilizing its trans-splicing ribozyme platform for early-stage research, while Eli Lilly manages later-stage development and global commercialization. This collaboration highlights the growing investment in RNA-editing technologies to deliver targeted therapies for genetic and rare diseases.

Major players in the ribonucleic acid (RNA) editing market are Moderna Inc., Arcturus Therapeutics Holdings Inc., CureVac AG, Beam Therapeutics Inc., EdiGene Inc., Ethris GmbH, Deep Genomics Incorporated, ProQR Therapeutics NV, ReCode Therapeutics, Capstan Therapeutics Inc., TriLink BioTechnologies, ADARx Pharmaceuticals Inc., Storm Therapeutics Limited, Ascidian Therapeutics Inc., Rznomics Inc., Airna Biotech S.L., hC Bioscience Inc., Korro Bio Inc., Shape TX, and Turn Biotechnologies.

North America was the largest region in the ribonucleic acid(RNA) editing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in ribonucleic acid (RNA) editing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the ribonucleic acid (RNA) editing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The ribonucleic acid (RNA) editing market consists of revenues earned by entities by providing services such as therapeutic ribonucleic acid (RNA) editing services, ribonucleic acid (RNA) editing delivery optimization, and bioinformatics and data analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. The ribonucleic acid (RNA) editing market also includes sales of ribonucleic acid (RNA) editing therapeutics, diagnostic kits, and ribonucleic acid (RNA) editing delivery systems. Values in this market are 'factory gate' values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Ribonucleic Acid (RNA) Editing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on ribonucleic acid (rna) editing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for ribonucleic acid (rna) editing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The ribonucleic acid (rna) editing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Type: Messenger Ribonucleic Acid (RNA) Modification; Transfer Ribonucleic Acid (RNA) Modification; Ribosomal Ribonucleic Acid (RNA) Modification
2) By Technique: Insertion Or Deletion; Deamination
3) By Application: Cancer; Genetic Disorders; Temporary Maladies
Subsegments:
1) By Messenger Ribonucleic Acid(RNA) (Mrna) Modification: Base Editing; Adenosine Deaminase Acting On Ribonucleic Acid (RNA)-Mediated Editing; Site-Directed Ribonucleic Acid (RNA) Editing
2) By Transfer Ribonucleic Acid (RNA) (Trna) Modification: Pseudouridylation; Transfer Ribonucleic Acid Splicing; Inosine Modification
3) By Ribosomal Ribonucleic Acid (RNA) (Rrna) Modification: Pseudouridylation; Ribosomal Ribonucleic Acid (RNA) Maturation Pathway Modulation; Site-Specific Ribosomal Ribonucleic Acid (RNA) Editing
Companies Mentioned: Moderna Inc.; Arcturus Therapeutics Holdings Inc.; CureVac AG; Beam Therapeutics Inc.; EdiGene Inc.; Ethris GmbH; Deep Genomics Incorporated; ProQR Therapeutics NV; ReCode Therapeutics; Capstan Therapeutics Inc.; TriLink BioTechnologies; ADARx Pharmaceuticals Inc.; Storm Therapeutics Limited; Ascidian Therapeutics Inc.; Rznomics Inc.; Airna Biotech S.L.; hC Bioscience Inc.; Korro Bio Inc.; Shape TX; Turn Biotechnologies.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.

Product Code: r37878

1. Executive Summary

2. Ribonucleic Acid (RNA) Editing Market Characteristics

3. Ribonucleic Acid (RNA) Editing Market Trends And Strategies

4. Ribonucleic Acid (RNA) Editing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Ribonucleic Acid (RNA) Editing Growth Analysis And Strategic Analysis Framework

5.1. Global Ribonucleic Acid (RNA) Editing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Ribonucleic Acid (RNA) Editing Market Growth Rate Analysis
5.4. Global Ribonucleic Acid (RNA) Editing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Ribonucleic Acid (RNA) Editing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Ribonucleic Acid (RNA) Editing Total Addressable Market (TAM)

6. Ribonucleic Acid (RNA) Editing Market Segmentation

6.1. Global Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Messenger Ribonucleic Acid(RNA) Modification
Transfer Ribonucleic Acid(RNA) Modification
Ribosomal Ribonucleic Acid(RNA) Modification
6.2. Global Ribonucleic Acid (RNA) Editing Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Insertion Or Deletion
Deamination
6.3. Global Ribonucleic Acid (RNA) Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Cancer
Genetic Disorders
Temporary Maladies
6.4. Global Ribonucleic Acid (RNA) Editing Market, Sub-Segmentation Of Messenger Ribonucleic Acid(RNA) (Mrna) Modification, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Base Editing
Adenosine Deaminase Acting On Ribonucleic Acid(RNA)-Mediated Editing
Site-Directed Ribonucleic Acid (RNA) Editing
6.5. Global Ribonucleic Acid (RNA) Editing Market, Sub-Segmentation Of Transfer Ribonucleic Acid(RNA) (Trna) Modification, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Pseudouridylation
Transfer Ribonucleic Acid Splicing
Inosine Modification
6.6. Global Ribonucleic Acid (RNA) Editing Market, Sub-Segmentation Of Ribosomal Ribonucleic Acid(RNA) (Rrna) Modification, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Pseudouridylation
Ribosomal Ribonucleic Acid(RNA) Maturation Pathway Modulation
Site-Specific Ribosomal Ribonucleic Acid (RNA) Editing

7. Ribonucleic Acid (RNA) Editing Market Regional And Country Analysis

7.1. Global Ribonucleic Acid (RNA) Editing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Ribonucleic Acid (RNA) Editing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Ribonucleic Acid (RNA) Editing Market

8.1. Asia-Pacific Ribonucleic Acid (RNA) Editing Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Ribonucleic Acid (RNA) Editing Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Ribonucleic Acid (RNA) Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Ribonucleic Acid (RNA) Editing Market

9.1. China Ribonucleic Acid (RNA) Editing Market Overview
9.2. China Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Ribonucleic Acid (RNA) Editing Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Ribonucleic Acid (RNA) Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Ribonucleic Acid (RNA) Editing Market

10.1. India Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Ribonucleic Acid (RNA) Editing Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Ribonucleic Acid (RNA) Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Ribonucleic Acid (RNA) Editing Market

11.1. Japan Ribonucleic Acid (RNA) Editing Market Overview
11.2. Japan Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Ribonucleic Acid (RNA) Editing Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Ribonucleic Acid (RNA) Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Ribonucleic Acid (RNA) Editing Market

12.1. Australia Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Ribonucleic Acid (RNA) Editing Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Ribonucleic Acid (RNA) Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Ribonucleic Acid (RNA) Editing Market

13.1. Indonesia Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Ribonucleic Acid (RNA) Editing Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Ribonucleic Acid (RNA) Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Ribonucleic Acid (RNA) Editing Market

14.1. South Korea Ribonucleic Acid (RNA) Editing Market Overview
14.2. South Korea Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Ribonucleic Acid (RNA) Editing Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Ribonucleic Acid (RNA) Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Ribonucleic Acid (RNA) Editing Market

15.1. Western Europe Ribonucleic Acid (RNA) Editing Market Overview
15.2. Western Europe Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Ribonucleic Acid (RNA) Editing Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Ribonucleic Acid (RNA) Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Ribonucleic Acid (RNA) Editing Market

16.1. UK Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Ribonucleic Acid (RNA) Editing Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Ribonucleic Acid (RNA) Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Ribonucleic Acid (RNA) Editing Market

17.1. Germany Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Ribonucleic Acid (RNA) Editing Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Ribonucleic Acid (RNA) Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Ribonucleic Acid (RNA) Editing Market

18.1. France Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Ribonucleic Acid (RNA) Editing Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Ribonucleic Acid (RNA) Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Ribonucleic Acid (RNA) Editing Market

19.1. Italy Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Ribonucleic Acid (RNA) Editing Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Ribonucleic Acid (RNA) Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Ribonucleic Acid (RNA) Editing Market

20.1. Spain Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Ribonucleic Acid (RNA) Editing Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Ribonucleic Acid (RNA) Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Ribonucleic Acid (RNA) Editing Market

21.1. Eastern Europe Ribonucleic Acid (RNA) Editing Market Overview
21.2. Eastern Europe Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Ribonucleic Acid (RNA) Editing Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Ribonucleic Acid (RNA) Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Ribonucleic Acid (RNA) Editing Market

22.1. Russia Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Ribonucleic Acid (RNA) Editing Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Ribonucleic Acid (RNA) Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Ribonucleic Acid (RNA) Editing Market

23.1. North America Ribonucleic Acid (RNA) Editing Market Overview
23.2. North America Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Ribonucleic Acid (RNA) Editing Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Ribonucleic Acid (RNA) Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Ribonucleic Acid (RNA) Editing Market

24.1. USA Ribonucleic Acid (RNA) Editing Market Overview
24.2. USA Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Ribonucleic Acid (RNA) Editing Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Ribonucleic Acid (RNA) Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Ribonucleic Acid (RNA) Editing Market

25.1. Canada Ribonucleic Acid (RNA) Editing Market Overview
25.2. Canada Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Ribonucleic Acid (RNA) Editing Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Ribonucleic Acid (RNA) Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Ribonucleic Acid (RNA) Editing Market

26.1. South America Ribonucleic Acid (RNA) Editing Market Overview
26.2. South America Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Ribonucleic Acid (RNA) Editing Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Ribonucleic Acid (RNA) Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Ribonucleic Acid (RNA) Editing Market

27.1. Brazil Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Ribonucleic Acid (RNA) Editing Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Ribonucleic Acid (RNA) Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Ribonucleic Acid (RNA) Editing Market

28.1. Middle East Ribonucleic Acid (RNA) Editing Market Overview
28.2. Middle East Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Ribonucleic Acid (RNA) Editing Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Ribonucleic Acid (RNA) Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Ribonucleic Acid (RNA) Editing Market

29.1. Africa Ribonucleic Acid (RNA) Editing Market Overview
29.2. Africa Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Ribonucleic Acid (RNA) Editing Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Ribonucleic Acid (RNA) Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Ribonucleic Acid (RNA) Editing Market Competitive Landscape And Company Profiles

30.1. Ribonucleic Acid (RNA) Editing Market Competitive Landscape
30.2. Ribonucleic Acid (RNA) Editing Market Company Profiles
- 30.2.1. Moderna Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Arcturus Therapeutics Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. CureVac AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Beam Therapeutics Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. EdiGene Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Ribonucleic Acid (RNA) Editing Market Other Major And Innovative Companies

31.1. Ethris GmbH
31.2. Deep Genomics Incorporated
31.3. ProQR Therapeutics NV
31.4. ReCode Therapeutics
31.5. Capstan Therapeutics Inc.
31.6. TriLink BioTechnologies
31.7. ADARx Pharmaceuticals Inc.
31.8. Storm Therapeutics Limited
31.9. Ascidian Therapeutics Inc.
31.10. Rznomics Inc.
31.11. Airna Biotech S.L.
31.12. hC Bioscience Inc.
31.13. Korro Bio Inc.
31.14. Shape TX
31.15. Turn Biotechnologies

32. Global Ribonucleic Acid (RNA) Editing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Ribonucleic Acid (RNA) Editing Market

34. Recent Developments In The Ribonucleic Acid (RNA) Editing Market

35. Ribonucleic Acid (RNA) Editing Market High Potential Countries, Segments and Strategies

35.1 Ribonucleic Acid (RNA) Editing Market In 2029 - Countries Offering Most New Opportunities
35.2 Ribonucleic Acid (RNA) Editing Market In 2029 - Segments Offering Most New Opportunities
35.3 Ribonucleic Acid (RNA) Editing Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer